Together, according to our analysis, high FAP expression predicts a poorer prognosis for glioma patients, elevated FAP expression correlates with non‐codeletion of 1p19q, wild‐type IDH1 status, and old age, and FAP might serve as a biomarker for predicting overall survival. This evidence concerns the gene FAP and central nervous system cancer.